# Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis

> **NCT02953379** · PHASE3 · WITHDRAWN · sponsor: **EMS**

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** EMS Mometasone gel
- **DRUG:** Mometasone spray nasal

## Key facts

- **NCT ID:** NCT02953379
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-05
- **Primary completion:** 2019-12
- **Final completion:** 2020-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2020-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02953379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02953379, "Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02953379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*